PAG
HUMA icon

Private Advisor Group’s Humacyte HUMA Stock Holding History

Private Advisor Group’s Portfolio HUMA Stock Details HUMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$753K Buy
965,091
+132,292
+16% +$123K ﹤0.01% 1524
2026
Q1 		$505K Buy
832,799
+271,222
+48% +$282K ﹤0.01% 1845
2025
Q4 		$539K Sell
561,577
-467,503
-45% -$662K ﹤0.01% 1771
2025
Q3 		$1.79M Buy
1,029,080
+26,400
+3% +$51.7K 0.01% 1068
2025
Q2 		$2.1M Buy
1,002,680
+338,800
+51% +$651K 0.01% 939
2025
Q1 		$1.13M Buy
663,880
+64,180
+11% +$241K 0.01% 1183
2024
Q4 		$3.03M Buy
599,700
+226,590
+61% +$1.12M 0.02% 706
2024
Q3 		$2.03M Buy
373,110
+6,510
+2% +$42.9K 0.01% 875
2024
Q2 		$1.76M Buy
366,600
+48,976
+15% +$255K 0.01% 895
2024
Q1 		$988K Buy
317,624
+222,144
+233% +$747K 0.01% 1165
2023
Q4 		$271K Buy
95,480
+500
+0.5% +$1.28K ﹤0.01% 1845
2023
Q3 		$278K Buy
94,980
+52,980
+126% +$175K ﹤0.01% 1674
2023
Q2 		$120K Buy
42,000
+12,500
+42% +$45.1K ﹤0.01% 1910
2023
Q1 		$91.2K Hold
29,500
– – ﹤0.01% 1876
2022
Q4 		$62 Buy
29,500
+5,000
+20% +$15.2K ﹤0.01% 1612
2022
Q3 		$80K Hold
24,500
– – ﹤0.01% 1800
2022
Q2 		$79K Buy
+24,500
New +$136K ﹤0.01% 1976

Other funds holding HUMA

AP
Antipodes Partners Royal Exchange, Australia $5.46B AUM 26.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $8.42B AUM 61.81% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $529M AUM 337.4% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Private Advisor Group's HUMA Position: Q2 2026 in Review

Private Advisor Group increased its Humacyte (HUMA) stake by 16% in Q2 2026, buying an estimated $123K and bringing the position to 965,091 shares worth $753K. The position accounts for ﹤0.01% of the portfolio, ranked #1524.

Private Advisor Group first reported a position in HUMA in Q2 2022 and has held it in 17 quarters since. The position peaked at $3.03M in Q4 2024. 161 funds tracked by Wall St. Rank hold HUMA as of Q2 2026.

  • Private Advisor Group held 965,091 shares of Humacyte worth $753K as of Q2 2026.
  • Private Advisor Group bought 132,292 Humacyte shares in Q2 2026, an estimated $123K.
  • Humacyte made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #1524 holding.
  • Private Advisor Group first reported a position in Humacyte in Q2 2022 and has held it in 17 quarters since.
  • Private Advisor Group's Humacyte position peaked at $3.03M in Q4 2024.
  • 161 funds tracked by Wall St. Rank held Humacyte as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.